Skip to main content
Top
Published in: International Journal of Hematology 3/2011

01-09-2011 | Case Report

Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma

Authors: Yasushi Terasaki, Hiroki Yamamoto, Hiroaki Kiyokawa, Hirokazu Okumura, Katsuhiko Saito, Ryo Ichinohasama, Youichi Ishida

Published in: International Journal of Hematology | Issue 3/2011

Login to get access

Abstract

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma usually confined to the body cavities of predominantly immunosuppressed patients infected with human herpes virus-8 (HHV-8). In PEL, malignant cells are usually negative for B-cell markers, such as CD19, CD20, and CD79a, but are positive for activation and plasma cell-related markers, such as CD30, CD38, and CD138. It has been reported that HHV-8-unrelated PEL shows high expression of B-cell markers, which is referred to as PEL-like lymphoma. Here, we report two cases of HHV-8-unrelated HIV-negative PEL-like lymphoma in which malignant cells regressed spontaneously after effusion drainage alone. These cells expressed B-cell markers, such as CD20. No chemotherapy was given to either patient, as they were of an advanced age, and both achieved a complete response by effusion drainage alone. One showed a complete response for 16 months after effusion drainage, and the other has survived for 11 months with a complete response. This suggests that sufficient drainage of serous effusion may induce and maintain a complete response in some patients with HHV-8-unrelated HIV-negative PEL-like lymphoma, which represents an excellent treatment option for elderly patients with this disease.
Literature
1.
go back to reference Said J, Ceaarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 260–1. Said J, Ceaarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 260–1.
2.
go back to reference Kobayashi Y, Kamitsuji Y, Kuroda J, Tsunoda S, Uoshima N, Kimura S, et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acuta Haematol. 2007;117:132–44.CrossRef Kobayashi Y, Kamitsuji Y, Kuroda J, Tsunoda S, Uoshima N, Kimura S, et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acuta Haematol. 2007;117:132–44.CrossRef
3.
go back to reference Adiguzel C, Bozkurt SU, Kaygusuz I, Uzay A, Tecimer T, Bayik M. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. APMIS. 2009;117:222–9.CrossRefPubMed Adiguzel C, Bozkurt SU, Kaygusuz I, Uzay A, Tecimer T, Bayik M. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. APMIS. 2009;117:222–9.CrossRefPubMed
4.
go back to reference Carbone A, Globhini A. PEL and HHV-unrelated effusion lymphomas: classification and diagnosis. Cancer. 2008;114:225–7.CrossRefPubMed Carbone A, Globhini A. PEL and HHV-unrelated effusion lymphomas: classification and diagnosis. Cancer. 2008;114:225–7.CrossRefPubMed
5.
go back to reference Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998;22:1528–37.CrossRefPubMed Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998;22:1528–37.CrossRefPubMed
6.
go back to reference Saiki M, Saitoh T, Inoue M, Hatta Y, Yamazaki T, Itoh T, et al. Human herpesvirus-8 negative primary effusion lymphoma with complete clinical remission after removal of ascites. Rinsho Ketsueki. 2002;43:548–53. Japanese.PubMed Saiki M, Saitoh T, Inoue M, Hatta Y, Yamazaki T, Itoh T, et al. Human herpesvirus-8 negative primary effusion lymphoma with complete clinical remission after removal of ascites. Rinsho Ketsueki. 2002;43:548–53. Japanese.PubMed
7.
8.
go back to reference Terasaki Y, Okumura H, Saito K, Sato Y, Yoshino T, Ichinohasama R, Ishida Y. HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. Intern Med. 2008;47:2175–8.CrossRefPubMed Terasaki Y, Okumura H, Saito K, Sato Y, Yoshino T, Ichinohasama R, Ishida Y. HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. Intern Med. 2008;47:2175–8.CrossRefPubMed
9.
go back to reference Suzuki K, Ino K, Sugawara Y, Mizutani M, Sekine T, Katayama N. Prolonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximab. Gan To Kagaku Ryoho. 2008;35:691–4. Japanese.PubMed Suzuki K, Ino K, Sugawara Y, Mizutani M, Sekine T, Katayama N. Prolonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximab. Gan To Kagaku Ryoho. 2008;35:691–4. Japanese.PubMed
10.
go back to reference De Filippi R, Iaccarino G, Frigeri F, Di Francia R, Crisci S, Capobianco G, et al. Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma. Br J Haematol. 2009;147:405–8.CrossRefPubMed De Filippi R, Iaccarino G, Frigeri F, Di Francia R, Crisci S, Capobianco G, et al. Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma. Br J Haematol. 2009;147:405–8.CrossRefPubMed
11.
go back to reference Tsagarakis NJ, Argyrou A, Gortzolidis G, Kentrou N, Papadhimitriou SI, Tzanetou K, et al. Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia. Int J Hematol. 2009;90:94–8.CrossRefPubMed Tsagarakis NJ, Argyrou A, Gortzolidis G, Kentrou N, Papadhimitriou SI, Tzanetou K, et al. Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia. Int J Hematol. 2009;90:94–8.CrossRefPubMed
12.
go back to reference Taira T, Nagasaki A, Okudaira T, Miyagi T, Iha K, Takushi Y, et al. HIV- and HHV-8-negative primary effusion lymphoma-like lymphoma presenting with lymphomatous effusions complicated by cardiac tamponade-a case report. Gan To Kagaku Ryoho. 2009;36:1195–8. Japanese.PubMed Taira T, Nagasaki A, Okudaira T, Miyagi T, Iha K, Takushi Y, et al. HIV- and HHV-8-negative primary effusion lymphoma-like lymphoma presenting with lymphomatous effusions complicated by cardiac tamponade-a case report. Gan To Kagaku Ryoho. 2009;36:1195–8. Japanese.PubMed
13.
go back to reference Takahashi T, Hangaishi A, Yamamoto G, Ichikawa M, Imai Y, Kurokawa M. HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases. Am J Hematol. 2010;85:85–7.PubMed Takahashi T, Hangaishi A, Yamamoto G, Ichikawa M, Imai Y, Kurokawa M. HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases. Am J Hematol. 2010;85:85–7.PubMed
14.
go back to reference Kagoya Y, Takahashi T, Yoshimoto T, Ichikawa M, Hangaishi A, Fukayama M, et al. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case. Ann Hematol. 2011;90:219–20.CrossRefPubMed Kagoya Y, Takahashi T, Yoshimoto T, Ichikawa M, Hangaishi A, Fukayama M, et al. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case. Ann Hematol. 2011;90:219–20.CrossRefPubMed
15.
go back to reference Sandra Horning J, Saul Rosenberg A. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med. 1984;311:1471–5.CrossRef Sandra Horning J, Saul Rosenberg A. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med. 1984;311:1471–5.CrossRef
Metadata
Title
Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma
Authors
Yasushi Terasaki
Hiroki Yamamoto
Hiroaki Kiyokawa
Hirokazu Okumura
Katsuhiko Saito
Ryo Ichinohasama
Youichi Ishida
Publication date
01-09-2011
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2011
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0906-8

Other articles of this Issue 3/2011

International Journal of Hematology 3/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine